Convulsions in the first three years of life.

The Medical Journal of Australia
E J RossiterR D Pearson

Abstract

A prospective study of convulsions in 5803 consecutive newborn infants from an Australian city is described; 535 children were lost to study, leaving 90.9% of the original sample. Of the remaining 5268, 325 had at least one convulsive episode during the first three years of life--an incidence of 61.7 per thousand. Convulsions following breath-holding attacks were experienced by 8.1 per thousand, while a further 4.0 per thousand had simple breath-holding attacks associated with transient loss of consciousness, but no convulsion. Convulsions associated with fever were experienced by 39.9 per thousand. In addition, 8.2 per thousand had idiopathic convulsions, 2.8 per thousand had neonatal convulsions and 2.7 per thousand had convulsions of mixed aetiology. Factors relating to the convulsion are described in detail. Pregnancy and birth data are compared with those of a control group taken from the study.

References

Mar 1, 1977·Archives of Disease in Childhood·N Rutter, O R Smales
Nov 4, 1976·The New England Journal of Medicine·K B Nelson, J H Ellenberg
Jun 1, 1969·Archives of Disease in Childhood·J H Keen
Aug 1, 1954·Archives of Disease in Childhood·J B BURKE
Mar 1, 1964·Archives of Neurology·M A FALCONERJ A CORSELLIS
Dec 1, 1964·Epilepsia·E N ARNAUTOVA, T N NESMEIANOVA

❮ Previous
Next ❯

Citations

Oct 1, 1987·Postgraduate Medicine·R E Kaplan
Mar 1, 1981·Australian Paediatric Journal·E J Rossiter, J Luckin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.